🇺🇸 FDA

Company profile · Sponsor

Immedica

Immedica Pharma AB

E7C8865 · EMA pharma Stockholm, SE
Pipeline
1
Drugs
0
Patents
0

Quick answer

Immedica (E7C8865) is a pharma company. headquartered in Stockholm, SE. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E7C8865
Exchange EMA
Company type pharma
Headquarters Stockholm, SE

Pipeline (1)

Search pipeline →

  1. Loargys 5 mg/ml solution for injection/infusion

    Immedica

    Arginase 1 deficiency (ARG1-D)

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is Immedica?

Immedica (E7C8865) is a pharma company. headquartered in Stockholm, SE. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does Immedica sponsor?

We track 1 ClinicalTrials.gov-linked program for Immedica, including Loargys 5 mg/ml solution for injection/infusion. Open each program for phase, modality, NCT IDs, and indication details.

Where does Immedica company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.